Pulmonary function tests (PFTs) remain of foremost relevance to the management of patients with respiratory diseases. The recently published European Respiratory Society (ERS)/American Thoracic Society (ATS) document on testing interpretation is therefore poised to influence the way pulmonologists teach, describe and quantify respiratory physiological impairment [1]. A careful appraisal of its main recommendations is key to avoiding undesirable clinical consequences of any potential shortcomings.

中文翻译：

---

新的 ERS/ATS 肺功能测试解释标准：一些现存的限制

肺功能测试 (PFT) 仍然与呼吸系统疾病患者的管理最相关。因此，最近发表的欧洲呼吸学会 (ERS)/美国胸科学会 (ATS) 关于测试解释的文件有望影响肺科医生教授、描述和量化呼吸生理损伤的方式 [1]。仔细评估其主要建议是避免任何潜在缺陷的不良临床后果的关键。